Funds
Our portfolio is managed through a series of funds. Fund IV, focusing solely on therapeutics, is actively
pursuing new investment opportunities.
Funds
Portfolio companies
Million € invested
Million € returned to investors
Sunstone Life Science Ventures Fund I
Sunstone Life Science Ventures Fund I was established at the inception of Sunstone in 2007. The total committed capital is EUR 200 million. The investment strategy included therapeutics, medical technology and diagnostics. The fund is no longer making new investments.
Sunstone Life Science Ventures Fund II
Sunstone Life Science Ventures Fund II was established at the inception of Sunstone in 2007. The total committed capital is EUR 86 million and the fund invested in 12 new portfolio companies. The investment strategy included therapeutics, medical technology and diagnostics. The fund is no longer making new investments.
Sunstone Biomedical Ventures Fund I-III
In 2010, Sunstone took over management of the former BankInvest Biotechnology Funds. The funds are no longer making new investments.
Sunstone Life Science Ventures Fund III
Sunstone Life Science Ventures Fund III was established in 2012. The total committed capital is EUR 80 million and the fund invested in 11 new portfolio companies. The investment strategy included therapeutics, and medical technology. The fund is no longer making new investments.
Sunstone Life Science Ventures Fund IV
Sunstone Life Science Ventures Fund IV was established in 2019. The total committed capital is EUR 92 million. The investment strategy is focused entirely on therapeutics. The fund is currently building the portfolio and is actively pursuing new investment opportunities.